A Retrospective Evaluation of Clinical Profile of Second Primary Head and Neck Cancer
Introduction: Incidence of Second Primary Malignancy (SPM) after successful treatment of primary is increasing and may cause the problem for optimal treatment. Aim: This study was conducted retrospectively to analyse incidence, disease free survival between malignancies, pattern of treatment an...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
JCDR Research and Publications Private Limited
2016-10-01
|
Series: | Journal of Clinical and Diagnostic Research |
Subjects: | |
Online Access: | https://jcdr.net/articles/PDF/8725/21069_CE[Ra]_F(P)_PF1(ROAK)_PFA(NC)_PF2(PAG).pdf |
Summary: | Introduction: Incidence of Second Primary Malignancy (SPM)
after successful treatment of primary is increasing and may
cause the problem for optimal treatment.
Aim: This study was conducted retrospectively to analyse
incidence, disease free survival between malignancies, pattern
of treatment and outcome.
Materials and Methods: Sixteen out of 22 patients of previously
treated cases of head and neck cancer those develop SPM of
head and neck region managed over a period of January 2012
to December 2015 in Department of Radiotherapy–II, Pt. BD
Sharma PGIMS, Rohtak were analyzed retrospectively. Sixteen
patients with unresectable disease were given reirradiation with
external beam radiotherapy.
Results: Median age of presentation of first malignancy was 27
years (Ranged 26 -65 years), whereas median age was 60 years
for second malignancy (range 45-71 years). All patients were
smokers during first malignancy; 87.5% (14/16) had historyof
smoking during second malignancy. Oropharynx (50%) was
most common site of presentation of primary tumor whereas
oral cavity was most common site of presentation in second
primary tumor.
Conclusion: Incidence of Second primary head and neck tumor
after successful treatment for primary Head and neck cancer
are increasing due to newer treatment strategies, longer survival
and follow up. Reirradiation, surgery and or chemotherapy are
treatment modalities. However second primary tumor of this
region are associated with poor prognosis. |
---|---|
ISSN: | 2249-782X 0973-709X |